192 related articles for article (PubMed ID: 23587473)
1. Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.
Mangia A; Santoro R; Copetti M; Massari M; Piazzolla V; Spada E; Cappucci G; Missale G; Mottola L; Agostinacchio E; Mauro Ld; Zuccaro O; Maio P; Pellegrini F; Folgori A; Ferrari C
J Hepatol; 2013 Aug; 59(2):221-8. PubMed ID: 23587473
[TBL] [Abstract][Full Text] [Related]
2. Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection.
Beinhardt S; Aberle JH; Strasser M; Dulic-Lakovic E; Maieron A; Kreil A; Rutter K; Staettermayer AF; Datz C; Scherzer TM; Strassl R; Bischof M; Stauber R; Bodlaj G; Laferl H; Holzmann H; Steindl-Munda P; Ferenci P; Hofer H
Gastroenterology; 2012 Jan; 142(1):78-85.e2. PubMed ID: 22192885
[TBL] [Abstract][Full Text] [Related]
3. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
[TBL] [Abstract][Full Text] [Related]
4. A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection.
Beinhardt S; Payer BA; Datz C; Strasser M; Maieron A; Dorn L; Grilnberger-Franz E; Dulic-Lakovic E; Stauber R; Laferl H; Aberle JH; Holzmann H; Krall C; Vogel W; Ferenci P; Hofer H
J Hepatol; 2013 Nov; 59(5):972-7. PubMed ID: 23850880
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel.
Maor Y; Morali G; Bashari D; Pénaranda G; Schapiro JM; Martinowitz U; Halfon P
Haemophilia; 2013 Jan; 19(1):150-6. PubMed ID: 22913807
[TBL] [Abstract][Full Text] [Related]
6. IL28B CC-genotype association with HLA-DQB1*0301 allele increases the prediction of spontaneous HCV RNA clearance in thalassaemic HCV-infected patients.
Mangia A; Santoro R; Sarli R; Mottola L; Piazzolla V; Petruzzellis D; Bacca D; Clemente R; Copetti M; di Mauro L; Lotti G; Sacco M; Stefano I
Antivir Ther; 2011; 16(8):1309-16. PubMed ID: 22155912
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin.
Chen Y; Xu HX; Wang LJ; Liu XX; Mahato RI; Zhao YR
Aliment Pharmacol Ther; 2012 Jul; 36(2):91-103. PubMed ID: 22591106
[TBL] [Abstract][Full Text] [Related]
8. Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study.
Kamal SM; Kassim SK; Ahmed AI; Mahmoud S; Bahnasy KA; Hafez TA; Aziz IA; Fathelbab IF; Mansour HM
Am J Gastroenterol; 2014 Feb; 109(2):199-211. PubMed ID: 24445571
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
Sticchi L; Di Biagio A; Sartini M; Rappazzo E; Nicolini LA; Cenderello G; Valle C; Azzola E; Grasso A; De Leo P; Boldrini A; Setti M; Prinapori R; Lorusso C; Bruzzone B; Icardi G;
New Microbiol; 2015 Oct; 38(4):499-509. PubMed ID: 26485009
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients.
Pineda JA; Caruz A; Di Lello FA; Camacho A; Mesa P; Neukam K; Rivero-juárez A; Macías J; Gómez-Mateos J; Rivero A
AIDS; 2011 Jul; 25(11):1415-20. PubMed ID: 21572301
[TBL] [Abstract][Full Text] [Related]
12. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.
Grebely J; Petoumenos K; Hellard M; Matthews GV; Suppiah V; Applegate T; Yeung B; Marks P; Rawlinson W; Lloyd AR; Booth D; Kaldor JM; George J; Dore GJ;
Hepatology; 2010 Oct; 52(4):1216-24. PubMed ID: 20803561
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.
Samimi-Rad K; Sadeghi F; Amirzargar A; Eshraghian MR; Alavian SM; Rahimnia R
J Med Virol; 2015 Sep; 87(9):1565-72. PubMed ID: 25970464
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.
Tillmann HL; Thompson AJ; Patel K; Wiese M; Tenckhoff H; Nischalke HD; Lokhnygina Y; Kullig U; Göbel U; Capka E; Wiegand J; Schiefke I; Güthoff W; Grüngreiff K; König I; Spengler U; McCarthy J; Shianna KV; Goldstein DB; McHutchison JG; Timm J; Nattermann J;
Gastroenterology; 2010 Nov; 139(5):1586-92, 1592.e1. PubMed ID: 20637200
[TBL] [Abstract][Full Text] [Related]
16. Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin.
de Rueda PM; López-Nevot MÁ; Sáenz-López P; Casado J; Martín-Casares A; Palomares P; Quiles R; Gila A; Romero-Gómez M; Pavón EJ; Muñoz JA; Carazo A; Sanz-Cameno P; Moreno-Otero R; Diago M; León J; Ruiz-Extremera A; Salmerón J
Am J Gastroenterol; 2011 Jul; 106(7):1246-54. PubMed ID: 21670772
[TBL] [Abstract][Full Text] [Related]
17. A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.
Halfon P; Bourliere M; Ouzan D; Maor Y; Renou C; Wartelle C; Pénaranda G; Tran A; Botta D; Oules V; Castellani P; Portal I; Argiro L; Dessein A
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):931-5. PubMed ID: 21900787
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection.
Laird ME; Mohsen A; Duffy D; Mamdouh R; LeFouler L; Casrouge A; El-Daly M; Rafik M; Abdel-Hamid M; Soulier A; Pawlotsky JM; Hézode C; Rosa I; Renard P; Mohamed MK; Bonnard P; Izopet J; Mallet V; Pol S; Albert ML; Fontanet A
J Hepatol; 2014 Oct; 61(4):770-6. PubMed ID: 24905490
[TBL] [Abstract][Full Text] [Related]
19. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
[TBL] [Abstract][Full Text] [Related]
20. An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.
Mangia A; Thompson AJ; Santoro R; Piazzolla V; Tillmann HL; Patel K; Shianna KV; Mottola L; Petruzzellis D; Bacca D; Carretta V; Minerva N; Goldstein DB; McHutchison JG
Gastroenterology; 2010 Sep; 139(3):821-7, 827.e1. PubMed ID: 20621700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
